Rohto Pharmaceutical Co.,Ltd. (FRA:UC1)

Germany · Delayed Price · Currency is EUR

12.80

-0.20 (-1.54%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Unallocated Adjustment	-11.44B	-9.36B	-8.95B	-7.57B	-7.66B
Others	3.45B	2.83B	2.38B	1.96B	1.79B
Others Growth	21.94%	18.86%	21.23%	9.54%	1.88%
Asia	105.84B	83.11B	74.40B	58.92B	51.19B
Asia Growth	27.35%	11.71%	26.28%	15.08%	-9.01%
Japan	168.85B	160.17B	140.51B	124.80B	118.98B
Japan Growth	5.42%	13.99%	12.59%	4.89%	-0.19%
Europe	19.33B	14.02B	12.25B	10.34B	8.20B
Europe Growth	37.95%	14.44%	18.40%	26.12%	-7.74%
Americas	22.59B	20.07B	18.08B	11.19B	8.78B
Americas Growth	12.55%	11.05%	61.58%	27.44%	-16.24%
Total	308.62B	270.84B	238.66B	199.65B	181.29B
Total Growth	13.95%	13.48%	19.54%	10.13%	-3.74%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	163.65B	155.88B	134.78B	119.05B	114.60B
Japan Growth	4.98%	15.66%	13.21%	3.88%	-0.31%
Others	99.10B	74.75B	66.19B	47.85B	40.35B
Others Growth	32.58%	12.93%	38.32%	18.58%	-4.43%
China	45.87B	40.21B	37.70B	32.75B	26.34B
China Growth	14.09%	6.66%	15.12%	24.34%	-15.47%
Total	308.62B	270.84B	238.66B	199.65B	181.29B
Total Growth	13.95%	13.48%	19.54%	10.13%	-3.74%

Source: S&P Global Market Intelligence.